Searchable abstracts of presentations at key conferences in endocrinology

ea0020p76 | Thyroid | ECE2009

BRAFV600E mutation and timp-1 hyper-expression in classical variants of papillary thyroid carcinoma (PTC)

Bommarito Alessandra , Carissimi Elvira , Richiusa Pierina , Amato Marco Calogero , Russo Leonardo , Zito Giovanni , Pizzolanti Giuseppe , Giordano Carla

BRAFV600E mutation is considered useful in recognizing thyroid cancer aggressiveness or poor prognosis particularly in certain variants of papillary thyroid cancinoma (PTC). A recent meta-analysis identified 12 cancer-versus-non cancer gene candidate as markers of thyroid cancer; among these TIMP-1 (tissue inhibitors of metalloproteinases) was found consistently up-regulated. Our aim was to evaluate BRAFV600E mutation and TIMP-1 expression in 14 PTC class...

ea0020p126 | Thyroid | ECE2009

Antitumor effects of aminobisphosphonates on anaplastic thyroid carcinoma cell lines

Pitrone Maria , Zito Giovanni , Carissimi Elvira , Bommarito Alessandra , Richiusa Pierina , Galluzzo Aldo , Giordano Carla , Pizzolanti Giuseppe , Bullara V

Anaplastic thyropid carcinoma (ATC) is one of the most aggressive endocrine tumors with morphological features of undifferentiated neoplasm. Patients with ATC have a poor prognosis with a mean survival time of 2–6 months. Surgery, radiotherapy and chemotherapy do not improve survival rate. Bisphosphonates, analogs of endogenous pyrophosphates in which a carbon atom replaces the central oxygen atom, are successful agents for the prevention and treatment of postmenopausal o...

ea0016oc2.4 | Thyroid | ECE2008

Identification and enrichment of thyroid stem cells in anaplastic cell lines

Zito Giovanni , Richiusa Pierina , Pizzolanti Giuseppe , Bommarito Alessandra , Carissimi Elvira , Coppola Antonina , Nucera Miriam , Galluzzo Aldo , Giordano Carla

In the last years, a growing body of evidence supports the notion that tumors are organized in a hierarchy of heterogeneous cell populations with different biologic properties and that the capability to sustain tumor formation and growth exclusively resides in a small proportion of tumor cells, termed cancer stem cells (CSC). The existence of CSC was first proven in the context of acute myelogenous leukaemia, and subsequently verified in brain, breast, colon and prostate cance...

ea0016p428 | Neuroendocrinology | ECE2008

Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor (SSRI), during lifespan in humans

Berardelli Rita , Margarito Enrica , Ghiggia Federica , Picu Andreea , Bonelli Lorenza , Balbo Marcella , Giordano Roberta , Bo Mario , Arvat Emanuela

Central serotoninergic activity (CSA) is known to influence the hypothalamus–pituitary–adrenal (HPA) axis, and a CSA loss seems to play a role in human brain aging and in etiology of functional hypercortisolism and depression, whose incidence increase with advancing age. Citalopram (CT), a SSRI, has been considered a good tool to evaluate CSA in humans. Aim of this study was to evaluate the neuroendocrine response to CT in healthy adult subjects during lifespan. We e...

ea0016p822 | Thyroid | ECE2008

No association between BRAFV600E and metalloproteinase activity in anaplastic thyroid cell lines

Carissimi Elvira , Bommarito Alessandra , Pizzolanti Giuseppe , Zito Giovanni , Richiusa Pierina , Russo Leonardo , Coppola Antonina , Smeraldi Lucia , Galluzzo Aldo , Giordano Carla

A strong evidence suggests the role of BRAFV600E mutation in determining the aggressiveness of thyroid cancer. To detect how the association of BRAF mutation could influence the aggressiveness of particular subtypes of thyroid tumors, we analysed a possible correlation between BRAFV600E and metalloproteinase (MMPs) activity, as its enhanced production could be an important determinant of tumor invasion. For this purpose, we investigated the activity and t...

ea0014p506 | (1) | ECE2007

Conventional glucocorticoid replacement therapy in patients with Addison’s disease: effects on metabolic and bone parameters

Balbo Marcella , Giordano Roberta , Bonelli Lorenza , Berardelli Rita , Picu Andreea , Benso Andrea , Bertagna Angela , Ghigo Ezio , Arvat Emanuela

In primary adrenal insufficiency hydrocortisone or cortisone are commonly used at doses of 30–37.5 mg/day as replacement therapy, though recent studies showed that cortisol normal production is about 5.7 mg/m2, equivalent to 20 mg/day of hydrocortisone, suggesting that supraphysiological doses are used. In 19 Addison’s disease patients (8 M, 11 F, 23–71 yr) under conventional glucocorticoid replacement therapy (37.5 mg cortisone/day) with low DHEAS le...

ea0011p599 | Neuroendocrinology and behaviour | ECE2006

Sensitivity and specificity of different provocative tests for the diagnosis of secondary hypoadrenalism in patients with hypothalamo-pituitary disorders

Picu A , Giordano R , Bonelli L , Balbo M , Pellegrino M , Berardelli R , Corneli G , Gasco V , Ghigo E , Arvat E

Insulin tolerance test (ITT) is considered the golden standard test to evaluate HPA axis in suspected hypopituitarism. Low dose (1 μg) ACTH1–24 short stimulation test (LDSST) and metyrapone are often used when ITT is contraindicated. The diagnostic reliability of LDSST is, however, controversial, as even this dose has been considered supramaximal, while very low ACTH doses have been suggested more reliable to assess the adrenal sensitivity. Thus, in...

ea0056p863 | Pituitary - Clinical | ECE2018

Interim results of a non-interventional, observational study evaluating the long-term safety and efficacy of pasireotide sc in Cushing’s disease

Giordano Carla , Schopohl Jochen , Yuen Kevin C J , Kriemler-Krahn Ulrike , Li Jiang , Maamari Ricardo , Manetti Luca

Introduction: Subcutaneous (sc) pasireotide effectively reduces cortisol levels, improves signs/symptoms and is generally well tolerated in Cushing’s disease (CD) patients, as shown in previous clinical trials. We report interim results from a multicentre, real-world observational study evaluating the long-term safety and efficacy of pasireotide sc in clinical practice in CD patients.Methods: Adults with CD, for whom surgery has failed or is not an ...

ea0073pep4.3 | Presented ePosters 4: Reproductive and Developmental Endocrinology | ECE2021

Effects of a very low-calorie ketogenic diet on androgen levels in overweight/obese men: a single-arm uncontrolled study

Cignarelli Angelo , Conte Eleonora , Genchi Valentina Annamaria , Giordano Fiorella , Leo Simona Di , Perrini Sebastio , Natalicchio Annalisa , Laviola Luigi , Giorgino Francesco

Low levels of testosterone and SHBG levels are often present in subjects with overweight and obesity; functional hypogonadism further alters the metabolic balance and may drag subjects in a sort of vicious cycle, reducing exercise and energy expenditure. The very low-calorie ketogenic diet (VLCKD) has been reported to rapidly reduce body weight, glycaemia and insulinemia, but its effects on total testosterone (TT) and SHBG levels are less clear. We thus aimed to evaluate the r...

ea0081p606 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The ecology of the microbiome in children with congenital generalized lipodystrophy type 4 (CGL4) is quickly modified after metreleptin treatment

Daffara Tommaso , Mancioppi Valentina , Caputo Marina , Bellone Simonetta , Massa Nadia , Caramaschi Alice , Mignone Flavio , Romanisio Martina , Rabbone Ivana , Giordano Mara , Aimaretti Gianluca , Bona Elisa , Prodam Flavia

Introduction: Lipodystrophy syndromes are characterized by a progressive metabolic impairment secondary to adipose tissue dysfunction and genetic background. The role of microbiota is still uninvestigated.Objective: Evaluate the gut microbiome ecology in relation to dietary and clinical parameters in two infant siblings with congenital generalized lipodystrophy type 4 (CGL4) before and after treatment with recombinant leptin.Method...